Kyoji Ueda, Y. Hanazono, N. Ageyama, H. Shibata, Satoko Ogata, Y. Ueda, T. Tabata, S. Ikehara, M. Taniwaki, M. Hasegawa, K. Terao, K. Ozawa
{"title":"方法-非人灵长类动物造血干细胞骨髓内移植:无条件长期植入","authors":"Kyoji Ueda, Y. Hanazono, N. Ageyama, H. Shibata, Satoko Ogata, Y. Ueda, T. Tabata, S. Ikehara, M. Taniwaki, M. Hasegawa, K. Terao, K. Ozawa","doi":"10.1163/1568558042457460","DOIUrl":null,"url":null,"abstract":"It has recently been reported that bone marrow cells can efficiently engraft without marrow conditioning when implanted directly into the bone marrow cavity (intra-bone marrow transplantation, iBMT) in mice. We have successfully examined the efficacy of autologous iBMT in a cynomolgus monkey model in conjuction with an in vivo expansion of transplanted cells by a selective amplifier transgene (Ueda et al., 2004) and provide here the detailed parameters of our iBMT method. We injected retrovirally-marked autologous CD34+ cells directly into the non-conditioned marrow cavity of the femur and humerus after gently irrigating the cavity with saline. This transplant procedure was safely performed without pulmonary embolism. Gene-marked cells were not detectable in the peripheral blood at one hour and one day after iBMT as assessed by sensitive PCR, indicating that iBMT hardly generated a systemic delivery of transplanted cells. On the other hand, 2 to 30% of clonogenic hematopoietic colonies produced from the implanted marrow were gene-marked at 6–12 months after iBMT. Our iBMT method for non-human primates is thus discussed in terms of long-lived hematopoietic stem/progenitor cells, bone marrow niche and long-term engraftment after iBMT without myeloablative conditioning.","PeriodicalId":93646,"journal":{"name":"Gene therapy and regulation","volume":"2 1","pages":"207-218"},"PeriodicalIF":0.0000,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1163/1568558042457460","citationCount":"1","resultStr":"{\"title\":\"Method — Intra-bone marrow transplantation of hematopoietic stem cells in non-human primates: long-term engraftment without conditioning\",\"authors\":\"Kyoji Ueda, Y. Hanazono, N. Ageyama, H. Shibata, Satoko Ogata, Y. Ueda, T. Tabata, S. Ikehara, M. Taniwaki, M. Hasegawa, K. Terao, K. Ozawa\",\"doi\":\"10.1163/1568558042457460\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"It has recently been reported that bone marrow cells can efficiently engraft without marrow conditioning when implanted directly into the bone marrow cavity (intra-bone marrow transplantation, iBMT) in mice. We have successfully examined the efficacy of autologous iBMT in a cynomolgus monkey model in conjuction with an in vivo expansion of transplanted cells by a selective amplifier transgene (Ueda et al., 2004) and provide here the detailed parameters of our iBMT method. We injected retrovirally-marked autologous CD34+ cells directly into the non-conditioned marrow cavity of the femur and humerus after gently irrigating the cavity with saline. This transplant procedure was safely performed without pulmonary embolism. Gene-marked cells were not detectable in the peripheral blood at one hour and one day after iBMT as assessed by sensitive PCR, indicating that iBMT hardly generated a systemic delivery of transplanted cells. On the other hand, 2 to 30% of clonogenic hematopoietic colonies produced from the implanted marrow were gene-marked at 6–12 months after iBMT. Our iBMT method for non-human primates is thus discussed in terms of long-lived hematopoietic stem/progenitor cells, bone marrow niche and long-term engraftment after iBMT without myeloablative conditioning.\",\"PeriodicalId\":93646,\"journal\":{\"name\":\"Gene therapy and regulation\",\"volume\":\"2 1\",\"pages\":\"207-218\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2004-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1163/1568558042457460\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gene therapy and regulation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1163/1568558042457460\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gene therapy and regulation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1163/1568558042457460","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
最近有报道称,将骨髓细胞直接植入小鼠骨髓腔(intra-bone marrow transplantation, iBMT),无需骨髓调节即可有效植入。我们已经成功地在食蟹猴模型中检测了自体iBMT的有效性,并通过转基因选择放大器在体内扩增移植细胞(Ueda et al., 2004),并在这里提供了我们的iBMT方法的详细参数。我们将逆转录病毒标记的自体CD34+细胞直接注射到股骨和肱骨的非条件骨髓腔内,然后用盐水轻轻冲洗腔内。移植手术是安全的,没有肺栓塞。通过敏感PCR评估,在iBMT后1小时和1天的外周血中未检测到基因标记的细胞,表明iBMT几乎没有产生移植细胞的全身递送。另一方面,移植骨髓产生的2 - 30%的克隆造血菌落在iBMT后6-12个月被标记为基因。因此,我们对非人灵长类动物的iBMT方法进行了讨论,包括长期存活的造血干细胞/祖细胞、骨髓生态位和iBMT后无清髓条件的长期植入。
Method — Intra-bone marrow transplantation of hematopoietic stem cells in non-human primates: long-term engraftment without conditioning
It has recently been reported that bone marrow cells can efficiently engraft without marrow conditioning when implanted directly into the bone marrow cavity (intra-bone marrow transplantation, iBMT) in mice. We have successfully examined the efficacy of autologous iBMT in a cynomolgus monkey model in conjuction with an in vivo expansion of transplanted cells by a selective amplifier transgene (Ueda et al., 2004) and provide here the detailed parameters of our iBMT method. We injected retrovirally-marked autologous CD34+ cells directly into the non-conditioned marrow cavity of the femur and humerus after gently irrigating the cavity with saline. This transplant procedure was safely performed without pulmonary embolism. Gene-marked cells were not detectable in the peripheral blood at one hour and one day after iBMT as assessed by sensitive PCR, indicating that iBMT hardly generated a systemic delivery of transplanted cells. On the other hand, 2 to 30% of clonogenic hematopoietic colonies produced from the implanted marrow were gene-marked at 6–12 months after iBMT. Our iBMT method for non-human primates is thus discussed in terms of long-lived hematopoietic stem/progenitor cells, bone marrow niche and long-term engraftment after iBMT without myeloablative conditioning.